US FDA clears “first-ever” 24hr liquid SR drug
FDA approval for a 24-hour liquid sustained-release formulation could significantly improve tailored dosing, according to US developer Tris Pharma.
FDA approval for a 24-hour liquid sustained-release formulation could significantly improve tailored dosing, according to US developer Tris Pharma.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PharmaNet, Chiltern and Cardinal Health.
Preclinical drug testing specialist Absorption Systems has branched out and opened a new surgical lab designed to help pharmaceutical firms assess the safety of biomaterials and medical devices.
Repeated mandatory inspection of overseas API facilities should be performed to prevent falsified products entering the EU, according to a committee which has published proposed amendments to the draft directive.
Irish CRO Icon has received a US Food and Drug Administration (FDA) warning letter relating to two studies of an antibiotic it conducted between 2004 and 2006.
Dow has joined with Signet Healthcare Partners to form a new independent company which will use the chemical company’s Pfenex protein expression technology to accelerate development.